Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Middleton, G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 64 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Barker, V; Middleton, G; Davey, F; Davies, AM
      TNF alpha contributes to the death of NGF-dependent neurons during development

      NATURE NEUROSCIENCE
    2. Alonzi, T; Middleton, G; Wyatt, S; Buchman, V; Betz, UAK; Muller, W; Musiani, P; Poli, V; Davies, AM
      Role of STAT3 and Pl 3-Kinase/Akt in mediating the survival actions of cytokines on sensory neurons

      MOLECULAR AND CELLULAR NEUROSCIENCE
    3. Middleton, G; Wyatt, S; Ninkina, N; Davies, AM
      Reciprocal developmental changes in the roles of Bcl-w and Bcl-x(L) in regulating sensory neuron survival

      DEVELOPMENT
    4. Orike, N; Middleton, G; Borthwick, E; Buchman, V; Cowen, T; Davies, AM
      Role of PI 3-kinase, Akt and Bcl-2-related proteins in sustaining the survival of neurotrophic factor-independent adult sympathetic neurons

      JOURNAL OF CELL BIOLOGY
    5. Middleton, G; Wyatt, S; Cox, S; Korsmeyer, A; Davies, AM
      Differences in Bcl-2-and Bax-independent function in regulating apoptosis in sensory neuron populations

      EUROPEAN JOURNAL OF NEUROSCIENCE
    6. Middleton, G; Schoch, EM
      The prevalence of human thymic lymphoid follicles is lower in suicides

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    7. Gout, I; Middleton, G; Adu, J; Ninkina, NN; Drobot, LB; Filonenko, V; Matsuka, G; Davies, AM; Waterfield, M; Buchman, VL
      Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein

      EMBO JOURNAL
    8. Gallucci, NT; Middleton, G; Kline, A
      Perfectionism and creative strivings

      JOURNAL OF CREATIVE BEHAVIOR
    9. Middleton, G; Hamanoue, M; Enokido, Y; Wyatt, S; Pennica, D; Jaffray, E; Hay, RT; Davies, AM
      Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons

      JOURNAL OF CELL BIOLOGY
    10. Middleton, G; Munro, D; Dai, CP; Morris, P; Lum, C; Williams, D; Watson, P; Gee, W; Johal, S; Reath, S; Yuen, B; Hussein, A
      Second-growth western hemlock product yields and attributes related to stand density

      SUSTAINABLE PRODUCTION OF FOREST PRODUCTS 2000, PROCEEDINGS
    11. Hamanoue, M; Middleton, G; Wyatt, S; Jaffray, E; Hay, RT; Davies, AM
      p75-mediated NF-kappa B activation enhances the survival response of developing sensory neurons to nerve growth factor

      MOLECULAR AND CELLULAR NEUROSCIENCE
    12. Wyatt, S; Middleton, G; Doxakis, E; Davies, AM
      Selective regulation of trkC expression by NT3 in the developing peripheral nervous system

      JOURNAL OF NEUROSCIENCE
    13. Gallucci, NT; Middleton, G; Kline, A
      The independence of creative potential and behavior disorders in gifted children

      GIFTED CHILD QUARTERLY
    14. MIDDLETON G; PINON LGP; WYATT S; DAVIES AM
      BCL-2 ACCELERATES THE MATURATION OF EARLY SENSORY NEURONS

      The Journal of neuroscience
    15. MIDDLETON G
      GERARD-V.-MIDDLETON-DISTINGUISHED-EDUCATOR-AWARD - RESPONSE

      AAPG bulletin
    16. MIDDLETON G; SCHOCH EM
      THE PREVALENCE AND AGE DISTRIBUTION OF HUMAN THYMIC B-LYMPHOID FOLLICLES

      Pathology
    17. BROWN AL; MIDDLETON G; MACVICAR AD; HUSBAND JES
      T1-WEIGHTED MAGNETIC-RESONANCE-IMAGING IN BREAST-CANCER VERTEBRAL METASTASES - CHANGES ON TREATMENT AND CORRELATION WITH RESPONSE TO THERAPY

      Clinical Radiology
    18. Brown, AL; Middleton, G; Macvicar, AD; Husband, JES
      T1-weighted magnetic resonance imaging in breast cancer vertebral metastases: Changes on treatment and correlation with response to therapy (vol 53, pg 493, 1998)

      CLINICAL RADIOLOGY
    19. HICKISH TF; SMITH IE; OBRIEN MER; ASHLEY S; MIDDLETON G
      CLINICAL BENEFIT FROM PALLIATIVE CHEMOTHERAPY IN NONSMALL CELL LUNG-CANCER EXTENDS TO THE ELDERLY AND THOSE WITH POOR PROGNOSTIC FACTORS

      British Journal of Cancer
    20. Hickish, TF; Smith, IE; Nicolson, MC; Ashley, S; Priest, K; Spencer, L; Norman, A; Middleton, G; O'Brien, MER
      A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapyin small-cell lung cancer

      BRITISH JOURNAL OF CANCER
    21. HILTON M; MIDDLETON G; DAVIES AM
      BCL-2 INFLUENCES AXONAL GROWTH-RATE IN EMBRYONIC SENSORY NEURONS

      Current biology
    22. VERRILL M; MIDDLETON G; PRIEST K; SPENCER L; CHITTENDEN S; MCCREADY R; COX N; SKELTON L; OBRIEN M; SMITH I
      PHASE-I STUDY OF THE BIODISTRIBUTION, PHARMACOKINETICS AND IMMUNOGENICITY OF IN-111-HCTMO1 (CDP671)+ - PREDOSING WITH UNLABELED HCTMO1 IN PATIENTS (PTS) WITH LUNG-CANCER/

      European journal of cancer
    23. PINON LGP; MIDDLETON G; DAVIES AM
      BCL-2 IS REQUIRED FOR CRANIAL SENSORY NEURON SURVIVAL AT DEFINED STAGES OF EMBRYONIC-DEVELOPMENT

      Development
    24. MEHTA J; POWLES R; SINGHAL S; HORTON C; MIDDLETON G; EISEN T; MELLER S; PINKERTON CR; TRELEAVEN J
      EARLY IDENTIFICATION OF PATIENTS AT RISK OF DEATH DUE TO INFECTIONS, HEMORRHAGE, OR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION ON THE BASIS OF THE LEUKOCYTE COUNTS

      Bone marrow transplantation
    25. SANDERCOCK P; COLLINS R; COUNSELL C; FARRELL B; PETO R; SLATTERY J; WARLOW C; ANDERSON S; BOWIE A; BOYLE J; BROWNLIE A; CHARLTON D; CRANSWICK G; DAY L; DENNIS M; DORMAN P; FRASER H; KAYE M; LINDLEY R; LIU M; MACDONALD C; MCCRINDLE I; MIDDLETON G; PERRY D; SCOLTOCK V; SMITH B; TAYLOR H; WADDELL F; WARDLAW J; CROWTHER J; HEINEMAN J; KNIGHT S; RADLEY A; RIPLEY R; RICHARDS S; WILBERFORCE S; CHEN ZM; VANGIJN J; HARRISON M; WILHELMSEN L
      THE INTERNATIONAL STROKE TRIAL (IST) - A RANDOMIZED TRIAL OF ASPIRIN,SUBCUTANEOUS HEPARIN, BOTH, OR NEITHER AMONG 19 435 PATIENTS WITH ACUTE ISCHEMIC STROKE

      Lancet
    26. DAVIES AM; KORSMEYER S; PINON L; ADUL J; MIDDLETON G
      THE ROLE OF THE BCL-2 FAMILY OF PROTEINS IN REGULATING NEURONAL SURVIVAL

      British Journal of Pharmacology
    27. RAJE N; POWLES R; KULKARNI S; MILAN S; MIDDLETON G; SINGHAL S; MEHTA J; MILLAR B; VINER C; RAYMOND J; TRELEAVEN J; CUNNINGHAM D; GORE M
      A COMPARISON OF VINCRISTINE AND DOXORUBICIN INFUSIONAL CHEMOTHERAPY WITH METHYLPREDNISOLONE (VAMP) WITH THE ADDITION OF WEEKLY CYCLOPHOSPHAMIDE (C-VAMP) AS INDUCTION TREATMENT FOLLOWED BY AUTOGRAFTING IN PREVIOUSLY UNTREATED MYELOMA

      British Journal of Haematology
    28. RAJE N; POWLES R; HORTON C; MILLAR B; SHEPHERD V; MIDDLETON G; KULKARNI S; EISEN T; MEHTA J; SINGHAL S; TRELEAVEN J
      COMPARISON OF MARROW VS BLOOD-DERIVED STEM-CELLS FOR AUTOGRAFTING IN PREVIOUSLY UNTREATED MULTIPLE-MYELOMA

      British Journal of Cancer
    29. MIDDLETON G; NUNEZ G; DAVIES AM
      BAX PROMOTES NEURONAL SURVIVAL AND ANTAGONIZES THE SURVIVAL EFFECTS OF NEUROTROPHIC FACTORS

      Development
    30. MEHTA J; POWLES R; TRELEAVEN J; HORTON C; TAIT D; MELLER S; PINKERTON CR; MIDDLETON G; EISEN T; SINGHAL S
      LONG-TERM FOLLOW-UP OF PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST COMPLETE REMISSION AFTER CYCLOPHOSPHAMIDE-TOTAL BODY IRRADIATION AND CYCLOSPORINE

      Bone marrow transplantation
    31. MEHTA J; POWLES R; SINGHAL S; MATTHEY F; HAMBLIN M; MIDDLETON G; PRENDIVILLE J; GLYNNE P; ZOMAS A; TRELEAVEN J; CATOVSKY D
      T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FROM A PARTIALLY HLA-MISMATCHED UNRELATED DONOR FOR PROGRESSIVE CHRONIC LYMPHOCYTIC-LEUKEMIA AND FLUDARABINE-INDUCED BONE-MARROW FAILURE

      Bone marrow transplantation
    32. MIDDLETON G
      MUTAGEN IN CIGARETTES AND FOGGY AIR

      Lancet
    33. MIDDLETON G; POWLES R; SINGHAL S; EISEN T; TRELEAVEN J; MEHTA J
      FACTORS AFFECTING ENGRAFTMENT AFTER UNPURGED AUTOGRAFTING IN ACUTE-LEUKEMIA

      British Journal of Haematology
    34. MIDDLETON G; MEHTA J; POWLES R; SINGHAL S; SWANSBURY GJ; TRELEAVEN J; CATOVSKY D
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA AND PROLYMPHOCYTIC LEUKEMIA

      British Journal of Haematology
    35. EISEN T; POWLES R; SINGHAL S; MIDDLETON G; TRELEAVEN J; MEHTA J
      IDARUBICIN HIGH-DOSE CYTARABINE AND ETOPOSIDE FOR REMISSION INDUCTIONIN PATIENTS WITH RELAPSED ACUTE-LEUKEMIA

      British Journal of Haematology
    36. EISEN T; POWLES R; SINGHAL S; MIDDLETON G; TRELEAVEN J; MEHTA J
      LONG-TERM FOLLOW-UP OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN FIRST REMISSION AFTER CYCLOPHOSPHAMIDE TOTAL-BODY IRRADIATION AND CYCLOSPORINE

      British Journal of Haematology
    37. RAJE N; POWLES R; HORTON CAP; MILAN S; MIDDLETON G; EISEN T; VINER C; TRELEAVEN J; CUNNINGHAM D
      SALVAGE TREATMENT WITH VAMP C-VAMP INFUSIONAL CHEMOTHERAPY AND HIGH-DOSE MELPHALAN IN REFRACTORY MYELOMAS

      British Journal of Haematology
    38. RAJE N; POWLES R; MILAN S; MIDDLETON G; EISEN T; MEHTA J; SINGHAL S; TRELEAVEN J
      AUTOGRAFTING IN MYELOMA PATIENTS WITH RENAL IMPAIRMENT

      British Journal of Haematology
    39. RAJE N; POWLES R; EISEN T; MIDDLETON G; FIELD M; MEHTA J; SINGHAL S; TRELEAVEN J; MILAN S
      A RANDOMIZED TRIAL OF SHORT-COURSE CONSOLIDATION CHEMOTHERAPY FOLLOWING HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA

      British Journal of Haematology
    40. HAMBLIN M; POWLES R; TRELEAVEN J; SASO R; SINGHAL S; MIDDLETON G; KULKARNI S; CABRAL S; MEHTA J
      DEFIBROTIDE FOR REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) AFTER BONE-MARROW TRANSPLANTATION

      Blood
    41. POWLES R; SINGHAL S; TRELEAVEN J; SWANSBURY GJ; MIN T; HORTON C; MIDDLETON G; EISEN T; CATOVSKY D; MEHTA J
      EFFECT OF KARYOTYPE ABNORMALITIES (INCLUDING FAILURE TO OBTAIN METAPHASES) ON RESPONSE TO INDUCTION CHEMOTHERAPY AND SURVIVAL IN ACUTE MYELOID-LEUKEMIA

      Blood
    42. KULKARNI S; POWLES R; EISEN T; TRELEAVEN J; SINGHAL S; MIDDLETON G; HORTON C; MEHTA J
      HIGH-DOSE CYTARABINE AND VP-16 WITH OR WITHOUT IDARUBICIN FOR RELAPSED ACUTE-LEUKEMIA

      Blood
    43. MEHTA J; POWLES R; SINGHAL S; RILEY U; SASO R; WILSON K; EISEN T; MIDDLETON G; TRELEAVEN J; CATOVSKY D
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - IMPORTANCE OF INFECTION PROPHYLAXIS

      Blood
    44. POWLES R; TRELEAVEN J; SINGHAL S; KULKARNI S; HORTON C; MIDDLETON G; EISEN T; MEHTA J
      HEMATOPOIESIS IN ACUTE MYELOID-LEUKEMIA PATIENTS IN LONG-TERM REMISSION AND AT RELAPSE - INFLUENCE OF PREVIOUS THERAPY

      Blood
    45. POWLES R; RAJE N; KULKARNI S; EISEN T; MIDDLETON G; FIELD M; MEHTA J; SINGHAL S; TRELEAVEN J; MILAN S
      THE FEASIBILITY OF SHORT-COURSE CONSOLIDATION CHEMOTHERAPY FOLLOWING HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA

      Blood
    46. RAJE N; POWLES R; KULKARNI S; MILAN S; MIDDLETON G; EISEN T; TRELEAVEN J
      AUTOGRAFTING IN MYELOMA PATIENTS WITH RENAL IMPAIRMENT

      Blood
    47. RAJE N; POWLES R; HORTON C; KULKARNI S; EISEN T; MIDDLETON G; TRELEAVEN J
      PREDICTORS OF EARLY RELAPSE FOLLOWING AUTOGRAFTING FOR MYELOMA

      Blood
    48. MEHTA J; POWLES R; SINGHAL S; MIDDLETON G; EISEN T; SASO R; KULKARNI S; WILSON K; BENJAMIN A; DENT J; ALTON P; KILLICK S; GRAVETT P; TRELEAVEN J
      INDUCTION OF GRAFT-VERSUS-HOST DISEASE AS IMMUNOTHERAPY OF LEUKEMIA RELAPSING AFTER ALLOGRAFTING - SINGLE-CENTER EXPERIENCE OF 28 ADULTS

      Blood
    49. MIDDLETON G; POWLES R; SINGHAL S; HORTON C; KULKARNI S; EISEN T; DENT J; TRELEAVEN J; MEHTA J
      BONE-MARROW TRANSPLANTATION FROM HLA-MISMATCHED FAMILY DONORS FOR ACUTE MYELOID-LEUKEMIA - 10-YEAR FOLLOW-UP

      Blood
    50. KULKARNI S; POWLES R; MEHTA J; HORTON C; TRELEAVEN J; MIDDLETON G; EISEN T; SINGHAL S
      THALIDOMIDE FOR ACUTE OR CHRONIC GRAFT-VERSUS-HOST DISEASE

      Blood
    51. POWLES R; TRELEAVEN J; SINGHAL S; KULKARNI S; HORTON C; MIDDLETON G; EISEN T; MEHTA J
      EARLY LYMPHOCYTE RECOVERY AFTER ALLOGRAFTING FOR ACUTE MYELOID-LEUKEMIA AND RISK OF RELAPSE - IDENTIFICATION OF PATIENTS WHO MAY BENEFIT FROM PROPHYLACTIC IMMUNOTHERAPY

      Blood
    52. HICKISH TF; SMITH IE; NICOLSON MC; PRIEST K; SPENCER L; ASHLEY S; NORMAN A; MIDDLETON G
      MVP (MITOMYCIN-C, VINBLASTINE AND CISPLATIN) CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER (SCLC)

      European journal of cancer
    53. POWLES R; RAJE N; HICKISH T; MIDDLETON G; MILAN S; MEHTA J; SINGHAL S; VINER C; TRELEAVEN J; CUNNINGHAM D
      SINGLE-CENTER RESULTS OF THERAPY INCLUDING AUTOGRAFTS IN PREVIOUSLY UNTREATED MYELOMA

      European journal of cancer
    54. SINGHAL S; POWLES R; CUNNINGHAM D; HICKISH T; MIDDLETON G; RAJE N; VINER C; MEHTA J
      2ND AUTOGRAFTS FOR RELAPSED MYELOMA

      European journal of cancer
    55. RAJE N; POWLES R; HORTON C; MIDDLETON G; HICKISH T; MEHTA J; SINGHAL S; MORTON C; PORTER H; VINER C; TRELEAVEN J
      PERIPHERAL-BLOOD TRANSPLANTS FOLLOWED BY MAINTENANCE INTERFERON IN MYELOMA

      European journal of cancer
    56. ANDERSON JR; ARMITAGE JO; VOSE JM; BIERMAN P; WEISENBURGER D; CUNNINGHAM D; OBRIEN MER; MIDDLETON G; WEBB A; MEAD GM; WHITEHOUSE JMA; PROCTOR SJ
      CHLVPP THERAPY FOR HODGKINS-DISEASE - EXPERIENCE OF 960 PATIENTS

      Annals of oncology
    57. MIDDLETON G; CUNNINGHAM D
      CURRENT OPTIONS IN THE MANAGEMENT OF GASTROINTESTINAL CANCER

      Annals of oncology
    58. HILL M; NORMAN A; CUNNINGHAM D; FINDLAY M; WATSON M; NICOLSON V; WEBB A; MIDDLETON G; AHMED F; HICKISH T; NICOLSON M; OBRIEN M; IVESON T; IVESON A; EVANS C
      IMPACT OF PROTRACTED VENOUS INFUSION FLUOROURACIL WITH OR WITHOUT INTERFERON ALFA-2B ON TUMOR RESPONSE, SURVIVAL, AND QUALITY-OF-LIFE IN ADVANCED COLORECTAL-CANCER

      Journal of clinical oncology
    59. HICKISH TF; SMITH IE; ASHLEY S; MIDDLETON G
      CHEMOTHERAPY FOR ELDERLY PATIENTS WITH LUNG-CANCER

      Lancet
    60. HICKISH TF; SMITH IE; MIDDLETON G; NICOLSON M
      PATIENT PREFERENCE FOR EXTENDED PALLIATIVE CHEMOTHERAPY FOR NONSMALL CELL LUNG-CANCER

      Lancet
    61. MIDDLETON G
      AWARD PRESENTED BY THE INTERNATIONAL-ASSOCIATION-OF-SEDIMENTOLOGISTS AT THE 14TH INTERNATIONAL SEDIMENTOLOGICAL CONGRESS IN RECIFE, BRAZIL - CITATION OF ALLEN,JOHN,R.L. FOR THE SORBY-MEDAL

      Sedimentology
    62. MIDDLETON G; KARP D; LEE E; CUSH J
      WEGENERS GRANULOMATOSIS PRESENTING AS LOWER BACK PAIN WITH PROSTATITIS AND URETERAL OBSTRUCTION

      Journal of rheumatology
    63. MIDDLETON G; REID LE; HARMON BV
      APOPTOSIS IN THE HUMAN THYMUS IN SUDDEN AND DELAYED DEATH

      Pathology
    64. MIDDLETON G; MCFARLIN J; LIPSKY P
      FIBROMYALGIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS

      Arthritis and rheumatism


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 00:43:51